(177)Lu-Dotatate therapy for the treatment of metastatic neuroendocrine tumours in a patient on haemodialysis—dosimetric considerations

We report on a case of a 68-year-old female, currently a dialysis-dependant patient with disseminated metastatic neuroendocrine tumour, treated with (177)Lu-Dotatate. As (177)Lu-Dotatate is cleared predominantly by the kidneys, there are concerns regarding the treatment plan strategy to avoid increa...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalogianni, Eleni, Ruiz, Danielle Louise, Corcoran, Benjamin James, Devlin, Lindsey Ann, Vivian, Gillian Claire, Mulholland, Nicola Jane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Institute of Radiology 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180827/
https://www.ncbi.nlm.nih.gov/pubmed/30363599
http://dx.doi.org/10.1259/bjrcr.20150177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180827/
https://www.ncbi.nlm.nih.gov/pubmed/30363599
http://dx.doi.org/10.1259/bjrcr.20150177

Ejemplares similares